Saturday, March 3, 2001
by Xavier Bosch Barcelona
British Medical Journal
All five political parties in the Catalan parliament in Spain have signed
a proposal to legalise the use of cannabis for therapeutic purposes. The
agreement asks the Catalan government to negotiate with the Spanish authorities
so that cannabis--either as a drug or as a standardised extract of the
plant--may be used to treat medical disorders.
Once the bill is approved in the Catalan parliament, it may be submitted
to the Spanish parliament for discussion and eventual voting.
The initiative came from a collective of 300 women with breast cancer
called the "Agata group" (after Saint Agata, who had her breasts
removed under torture) and from a journalist, Nuria Nogueras, who recently
died of the disease and who found the drug helpful during chemotherapy.
Since last September, the Agata collective has held meetings with representatives
of the five Catalan parties, as well as with the Catalan health department
and oncologists and pharmacologists.
After these meetings, all political parties agreed to draft and release
a consensus report to the Catalan parliament to decriminalise the therapeutic
use of cannabis. But the measure, even if approved in the Catalan parliament--as
is forecast--can take effect only if the Spanish ministry of health gives
the go-ahead. The ministry is the only body with the power to authorise
new drugs in Spain.
Mr Eduard Rius, head of the Catalan health department, has recently sent
a letter to Spain's health minister, Ms Celia Villalobos, asking her to
"back totally the importation of foreign drugs containing cannabis
derivatives."
Mr Rius, who is from the "Convergencia i Unio" conservative
party that is running the Catalan government, mainly supports the consumption
of cannabis in the form of pills as it makes it possible "to control
the dose more accurately."
The Catalan socialist and green parties, however, advocate smoking the
drug because, according to them, "the efficacy is higher."
The report said that cannabis contains over 60 chemical compounds, which
can be classified into two main groups: (a) tetrahydrocannabinoids and
(b) cannabidiols and cannabigerols. Whereas the first causes "psychoactive
effects and mitigates vomiting and anxiety in disorders that require aggressive
treatment, such as cancer or AIDS," the second group has "no
psychoactive effects but has anti-inflammatory efficacy, especially in
arthritis."
The consensus report also pointed out that despite scientific and clinical
evidence for the medical potential of cannabis, its illegality means that
it is not an option for many people. "Only a privileged and well
informed minority can take advantage of this therapeutic resource,"
it said.
The report highlighted the properties of cannabis to alleviate pain in
cancer and AIDS and said that it is especially useful in the fight against
"hunger loss, anxiety, and chemotherapy related vomiting." A
list of recent reports on the topic is also included.
Mr Ramon Colom, general director of the Drug Addictions and AIDS Department
of the Catalan government, said that if the health ministry approves cannabis
as a new drug, people might be able to start using it by the end of the
year.
A spokesman for the health ministry said that regardless of the Catalan
measure the Spanish National Plan on Drugs--a Home Office based body--is
currently studying the potential medical use of cannabis, and a decision
will be taken on the basis of the recommendations of the commissioned
studies under way.
On behalf of the Agata group, Mr Xavier Capdevila, Mrs Nogueras's husband,
said: "Since the beginning, we had wished that the initiative was
agreed by all political parties and not capitalised by only one."
Mr Capdevila added that a year ago when his wife started a second cycle
of chemotherapy "cannabis helped her to feel better, to make vomiting
disappear and to start to be hungry."
|